Loading...
Enter to save. Escape to cancel.
Enter key or toolbar Save button to save.
Shift-enter for new line.
Escape key or toolbar Revert button to cancel.
Click to edit caption

New Medicine for Lung Cancer

The MHRA approved serplulimab to treat fast-growing small cell lung cancer. It helps the immune system fight cancer cells.
Serplulimab is given in a drip every 3 weeks with other medicines. It helps people live longer. The MHRA checks it is safe and works well.
If you feel unwell from serplulimab, tell your doctor or nurse. You can also report it online. The MHRA checks medicine safety in the UK.

New Medicine for Lung Cancer

The MHRA approved serplulimab to treat fast-growing small cell lung cancer. It helps the immune system fight cancer cells.
Serplulimab is given in a drip every 3 weeks with other medicines. It helps people live longer. The MHRA checks it is safe and works well.
If you feel unwell from serplulimab, tell your doctor or nurse. You can also report it online. The MHRA checks medicine safety in the UK.